Search Results for keywords:"intellectual property"

The United States Patent and Trademark Office (USPTO) has extended the Expanded Collaborative Search Pilot (CSP) program for two more years, lasting until October 31, 2022. This program is a joint effort with the Japan Patent Office (JPO) and the Korean Intellectual Property Office (KIPO) to exchange search results for patent applications before any office issues a decision. The goal is to improve the quality and efficiency of patent examination by sharing these results early in the process. Applicants must meet specific requirements, such as filing complete applications and petitions, to participate in this program, which allows collaboration with multiple international patent offices.

The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, is considering granting sublicensable patent licenses to Simon Fraser University in Canada and Le Centre National de la Recherche Scientifique in France. These licenses relate to a technology involving fluorescent RNA-fluorophore complexes, useful for studying RNA in live cells. The aim is to consolidate patent rights to expedite the development and marketing of this technology. Interested parties can submit comments or license applications by March 16, 2021, to object to the granting of the exclusive patent license.

The United States Patent and Trademark Office (USPTO) is extending the deadline for public feedback on creating a national campaign to fight counterfeit and pirated products. The original call for comments was published on November 17, 2020, and sought insights from various groups, including those affected by counterfeit sales and public-private campaign experts. Through this notice, individuals have until March 12, 2021, to provide their input on developing strategies, education materials, and alerts to help consumers identify and avoid fake products. This extension aims to give more people the chance to share their thoughts and ideas.

A complaint was filed with the U.S. International Trade Commission by Spanx, LLC of Atlanta, Georgia, alleging patent infringement concerning certain shapewear garments. The commission has decided to investigate whether shapewear products imported into the U.S. infringe on the specified patents and whether there's a U.S. industry being harmed. The parties involved are Spanx, various Chinese companies, and other firms like Honeylove Sculptwear Inc. The commission may issue orders to stop these imports if they find violations of U.S. patent law.

The National Institute of Diabetes and Digestive and Kidney Diseases announced a closed meeting for reviewing grant applications. This meeting, to be held from March 5-7, 2025, will take place virtually and is closed to the public to protect confidential information. The discussions during this meeting may involve sensitive trade secrets, patentable material, or personal information, which necessitates privacy. For any inquiries, contact Charlene J. Repique, Ph.D., the Scientific Review Officer at the National Institutes of Health.

NASA plans to grant a patent license to a company called SynMatter LLC for inventions related to anti-corrosion materials. This license could be exclusive, co-exclusive, or partially exclusive, giving SynMatter LLC the right to use these inventions in the U.S. However, NASA invites written objections or competing applications by January 30, 2025, if anyone believes this license should not be granted. This process follows certain U.S. laws and regulations about licensing inventions developed with federal funding.

The United States Patent and Trademark Office (USPTO) is seeking public comments on the issue of secondary trademark infringement in the e-commerce sector. This request was initially published in the Federal Register on November 13, 2020, and invites insights from various stakeholders, including intellectual property rights holders and online marketplaces, on how traditional trademark laws apply to online platforms. The period for submitting comments has been extended until January 25, 2021, to allow more time for interested parties to participate. The USPTO is particularly interested in feedback on the effectiveness of current laws and any recommendations for improvement.

The memorandum outlines the U.S. government's policy to protect American companies from unfair foreign practices, especially in the tech industry. It states that the U.S. will impose tariffs and take other actions against countries that apply discriminatory taxes and regulations that hurt U.S. businesses. The document instructs various U.S. officials, including the Secretary of the Treasury and the Trade Representative, to identify these foreign practices, consider responding to them, and develop strategies to mitigate their impact on American companies. The goal is to enhance the competitiveness of U.S. businesses and prevent foreign countries from exploiting them financially.

The Department of Health and Human Services, specifically the National Institutes of Health (NIH), announced that certain government-owned inventions are available for licensing. One such invention involves the use of statins, like atorvastatin, to prevent hearing loss caused by chemotherapy drugs like cisplatin. Hearing loss is a common side effect for many cancer patients undergoing treatment, and statins are being explored to mitigate this issue. The announcement highlights both the potential applications for these statins in preventing hearing loss and the readiness of the technology for commercial development.

The Office of the United States Trade Representative announced a notice regarding changes to specific product exclusions from tariffs on Chinese goods. These tariffs, initially imposed in September 2018, were part of a larger action due to issues with China's policies on technology and intellectual property. The notice outlines technical amendments to certain product exclusions and their extensions that impact goods imported during specific periods between 2018 and 2020. The amendments involve modifications in the product classification terms related to zinc oxide in the Harmonized Tariff Schedule of the United States.